Preoperative levosimendan in ischemic mitral valve repair

Asian Cardiovascular and Thoracic Annals

Volumn 22, Issue 5, 2014, Pages 539-545

  Sharma, Pranav ^a   Malhotra, Amber ^a   Gandhi, Sanjay ^a   Garg, Pankaj ^a   Bishnoi, Arvind ^a   Gandhi, Hemang ^a  

^a UN Mehta Institute of Cardiology and Research Center   (India)

Author keywords

Cardiac valve annuloplasty; Cardiopulmonary bypass; Cardiotonic agents; Coronary artery bypass; Levosimendan; Ventricular function

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOSIMENDAN; NITRIC ACID DERIVATIVE; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEADACHE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MALE; MEAN ARTERIAL PRESSURE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PROPHYLAXIS; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; VOMITING; ADVERSE EFFECTS; CORONARY ARTERY DISEASE; DRUG EFFECTS; DRUG THERAPY; HEART LEFT VENTRICLE FUNCTION; HEART VALVE REPLACEMENT; HEMODYNAMICS; INDIA; MIDDLE AGED; MITRAL ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; HYDRAZONES; INDIA; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PYRIDAZINES; RESPIRATION, ARTIFICIAL; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84903596853     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492313499352     Document Type: Article

References (18)

1. Christakis GT, Fremes SE, Naylor CD, Chen E, Rao V and Goldman BS. Impact of preoperative risk and perioperative morbidity on ICU stay following coronary bypass surgery. Cardiovasc Surg 1996; 4: 29-35.
2. Loop FD, Higgins TL, Panda R, Pearce G and Estafanous FG. Myocardial protection during cardiac operations. Decreased morbidity and lower cost with blood cardioplegia and coronary sinus perfusion. J Thorac Cardiovasc Surg 1992; 104: 608-618.
3. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS and Warltier DC. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 1999; 34: 219-228.
4. Lilleberg J, Nieminen MS, Akkila J, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998; 19: 660-668.
5. WMA Declaration of Helsinki -Ethical Principles for Medical Research Involving Human Subjects. Available at: http://www.wma.net/en/30publications/ 10policies/b3. Accessed July 3, 2013.
6. Levin R, Degrange M, Del Mazo C, Tanus E and Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol 2012; 17: 125-130.
7. Tritapepe L, De Santis V, Vitale D, et al. Levosimendan pre-Treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009; 102: 198-204.
8. Bolling SF, Bies LE, Gallagher KP and Bove EL. Enhanced myocardial protection with adenosine. Ann Thorac Surg 1989; 47: 809-815.
9. Bhayana JN, Kalmbach T, Booth FV, Mentzer RM Jr and Schimert G. Combined antegrade/retrograde cardioplegia for myocardial protection: a clinical trial. J Thorac Cardiovasc Surg 1989; 98: 956-960.
10. Gillies M, Bellomo R, Doolan L and Buxton B. Benchto-bedside review: inotropic drug therapy after adult cardiac surgery -A systematic literature review. Crit Care 2005; 9: 266-279.
11. Dernellis J and Panaretou M. Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study. Chest 2005; 128: 2633-2639.
12. Antoniades C, Tousoulis D, Koumallos N, Marinou K and Stefanadis C. Levosimendan: beyond its simple inotropic effect in heart failure [Review]. Pharmacol Ther 2007; 114: 184-197.
13. Tasouli A, Papadopoulos K, Antoniou T, et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg 2007; 32: 629-633.
14. Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I and Wahba A. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function. Eur J Cardiothorac Surg 2009; 36: 1024-1030.
15. Alvarez J, Bouzada M, Fernandez AL, et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006; 59: 338-345.
16. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting -A pilot study. Br J Anaesth 2006; 96: 694-700.
17. Landoni G, Biondi-Zoccai G, Greco M, et al. Effects of levosimendan on mortality and hospitalization. A meta-Analysis of randomized controlled studies. Crit Care Med 2012; 40: 634-646.
18. Maharaj R and Metaxa V. Levosimendan and mortality after coronary revascularisation: a metaanalysis of randomised controlled trials. Crit Care 2011; 15: R140.